All terms in MESH
| Label | Id | Description |
|---|---|---|
| Enterobacteriaceae Infections | D004756 | [Infections with bacteria of the family ENTEROBACTERIACEAE.] |
| cytidine-5'-monophosphatase | C025221 | |
| Ureaplasma Infections | D016869 | [Infections with bacteria of the genus UREAPLASMA.] |
| Mycoplasmatales Infections | D009180 | [Infections with bacteria of the order MYCOPLASMATALES.] |
| Polybed 812 | C025222 | |
| 1,4-dioxane | C025223 | |
| 2-benzoquinone | C025225 | |
| oxytocin, 1-alpha-mercaptoacetic acid-iso-Asn(5)- | C025226 | |
| MIRA protein, Emericella nidulans | C446307 | |
| TogM protein, Erwinia chrysanthemi | C446308 | |
| TogN protein, Erwinia chrysanthemi | C446309 | |
| Caffeine | D002110 | [A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.] |
| Xanthines | D014970 | [Purine bases found in body tissues and fluids and in some plants.] |
| Calcaneus | D002111 | [The largest of the TARSAL BONES which is situated at the lower and back part of the FOOT, forming the HEEL.] |
| Tarsal Bones | D013639 | [The seven bones which form the tarsus - namely, CALCANEUS; TALUS; cuboid, navicular, and the internal, middle, and external cuneiforms.] |
| Calcifediol | D002112 | [The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties.] |
| Hydroxycholecalciferols | D006887 | [Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3.] |
| Calcification, Physiologic | D002113 | [Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts.] |
| Bone Development | D001846 | [The growth and development of bones from fetus to adult. It includes two principal mechanisms of bone growth: growth in length of long bones at the epiphyseal cartilages and growth in thickness by depositing new bone (OSTEOGENESIS) with the actions of OSTEOBLASTS and OSTEOCLASTS.] |
| Calcinosis | D002114 | [An extremely rare benign condition characterized by large calcified periarticular soft tissue masses composed of calcium salts, usually located around large joints. Tumoral calcinosis can occur due to HYPERPHOSPHATEMIA in patients with UREMIA and/or who are undergoing RENAL DIALYSIS., Pathologic deposition of calcium salts in tissues.] |